Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase IV Longitudinal Study of SUBLOCADE (SUBUTEX Prolonged Release) Clinical Outcomes in Adults With Opioid Use Disorder (Opioid Dependence)

NCT05860959 is registered in ClinicalTrials.gov with Indivior Inc. as lead sponsor.

NCT NCT05860959
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05860959 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase IV Longitudinal Study of SUBLOCADE (SUBUTEX Prolonged Release) Clinical Outcomes in Adults With Opioid Use Disorder (Opioid Dependence)
Lead sponsor
Indivior Inc.
Phase
Observational
Overall status
Completed
Start date
August 31, 2023
Completion date
August 31, 2025
Enrollment
480 (actual)
Sites
49

Conditions

As the registry lists them; a condition with its own page is linked.

opioid use disorder